In general, patients with primary hypogonadism display impaired levels of testosterone and elevated levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), while patients with secondary hypogonadism usually have reduced levels of testosterone and levels of LH and FSH on the lower end. The gene discussed is BRD2; the disease is hypogonadotropic hypogonadism.